MedRx Co., Ltd
Notice of Monthly Exercise Status of the 35th Stock Acquisition Rights issued through a Third-Party Allotment (exercise price adjustment clause)
Disclosure of the July monthly exercise status of the 35th stock acquisition rights allocated to Growth Capital. The number of issued shares is 5,936,500 shares; stock acquisition rights exercised in July total 59,365 units (40.16% of issued shares), with 7,939,500 shares remaining unexercised at month-end (79,395 units).
Key Figures
- Issuing of shares: 5,936,500 shares
- Number of stock acquisition rights exercised: 59,365 units
- Exercise ratio to total issued shares: 40.16%
- Unexercised stock acquisition rights at month-end (July): 79,395 units (7,939,500 shares)
AI要約
Section heading
This report details the monthly exercise status for the 35th stock acquisition rights issued through a third-party allotment for July 2026. The number of issued shares is 5,936,500; rights exercised in July amount to 59,365, with an exercise ratio of 40.16% of the issued shares. At month-end, unexercised rights stood at 79,395 units (7,939,500 shares), and compliance with the exchange rules on exercise restrictions is shown.
Section 2 heading
The report lists the breakdown of exercise status by date, detailing the number of issued shares and the number of exercised stock acquisition rights for each exercise date from July 1 to July 31. For compliance with exercise restrictions (Listing Rule 434), the total issued shares, listed shares, and the exercise ratio are provided, with the overall exercise ratio stated as 10.00%.
Medrexs Co., Ltd.
Company overview · Stock price · Financial data · All IR
